PFCS
DERM icon

Pale Fire Capital SE’s Journey Medical DERM Stock Holding History

Pale Fire Capital SE’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Buy
481,987
+37,345
+8% +$290K 0.2% 25
2025
Q4 		$3.43M Buy
444,642
+216,075
+95% +$1.69M 0.23% 25
2025
Q3 		$1.63M Buy
228,567
+196,109
+604% +$1.42M 0.18% 26
2025
Q2 		$233K Buy
32,458
+5,184
+19% +$35.8K 0.02% 40
2025
Q1 		$161K Buy
+27,274
New +$134K 0.02% 42

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Pale Fire Capital SE's DERM Position: Q1 2026 in Review

Pale Fire Capital SE increased its Journey Medical (DERM) stake by 8.4% in Q1 2026, buying an estimated $290K and bringing the position to 481,987 shares worth $2.26M. The position accounts for 0.2% of the portfolio, ranked #25.

Pale Fire Capital SE first reported a position in DERM in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.43M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Pale Fire Capital SE held 481,987 shares of Journey Medical worth $2.26M as of Q1 2026.
  • Pale Fire Capital SE bought 37,345 Journey Medical shares in Q1 2026, an estimated $290K.
  • Journey Medical made up 0.2% of Pale Fire Capital SE's portfolio in Q1 2026, its #25 holding.
  • Pale Fire Capital SE first reported a position in Journey Medical in Q1 2025 and has held it in 5 quarters since.
  • Pale Fire Capital SE's Journey Medical position peaked at $3.43M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.